ArticleHaematologica2013

The BCR-ABLT315I mutation compromises survival in chronic phase chronic myelogenous leukemia patients resistant to tyrosine kinase inhibitors, in a matched pair analysis.

Franck E Nicolini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.